Original price was: $599.00.$549.00Current price is: $549.00.
In Stock
Vectibix is intended for the treatment of metastatic colorectal cancer (mCRC) in adult patients with wild-type RAS genes in the tumor:
– as first line therapy in combination with regimens containing fluorouracil, calcium folinate and oxaliplatin (FOLFOX) or fluorouracil, calcium folinate and irinotecan (FOLFIRI);
– as second-line therapy in combination with a regimen containing fluorouracil, calcium folinate and irinotecan (FOLFIRI) in patients who have previously received first-line fluoropyrimidine-based chemotherapy (excluding irinotecan);
– as monotherapy when chemotherapy regimens based on fluoropyrimidine, oxaliplatin and irinotecan are ineffective.
Active ingredient: panitumumab
Prescription medicine
Storage temperature 2-8 degrees
